[HTML][HTML] Protein oxidation-Formation mechanisms, detection and relevance as biomarkers in human diseases

R Kehm, T Baldensperger, J Raupbach, A Höhn - Redox Biology, 2021 - Elsevier
Generation of reactive oxygen species and related oxidants is an inevitable consequence of
life. Proteins are major targets for oxidation reactions, because of their rapid reaction rates …

Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis

EEL Cho, CZ Ang, J Quek, CE Fu, LKE Lim, ZEQ Heng… - Gut, 2023 - gut.bmj.com
Introduction Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver
disease, with type 2 diabetes mellitus (T2DM) as a major predictor. Insulin resistance and …

Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice

H Yang, T Yang, C Heng, Y Zhou, Z Jiang… - Phytotherapy …, 2019 - Wiley Online Library
Multiphase pathological processes involve in Type 2 diabetes (T2DM)‐induced
nonalcoholic fatty liver disease (NAFLD). However, the therapies are quite limited. In the …

Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis

A Elhence, B Bansal, H Gupta, A Anand… - Journal of Clinical and …, 2022 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) contributes to a large proportion of
liver disease burden in the world. Several groups have studied the prevalence of NAFLD in …

[HTML][HTML] Association of hepatic steatosis index and fatty liver index with carotid atherosclerosis in type 2 diabetes

C Wang, Z Cai, X Deng, H Li, Z Zhao… - … Journal of Medical …, 2021 - ncbi.nlm.nih.gov
Background/aim: Previous studies have suggested that the hepatic steatosis index (HSI) and
fatty liver index (FLI) can be used as a predictor of non-alcoholic fatty liver disease (NAFLD) …

Serum malondialdehyde is associated with non-alcoholic fatty liver and related liver damage differentially in men and women

S Zelber-Sagi, D Ivancovsky-Wajcman, N Fliss-Isakov… - Antioxidants, 2020 - mdpi.com
Background: Non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) are
associated with increased oxidative stress and lipid peroxidation, but large studies are …

Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db/db mice

T Yang, H Yang, C Heng, H Wang, S Chen, Y Hu… - Food & function, 2020 - pubs.rsc.org
The intestinal microenvironment, a potential factor that contributes to the development of non-
alcoholic fatty liver disease (NALFD) and type 2 diabetes (T2DM), has a close relationship …

Targeting mTOR/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced …

T Yang, Y Wang, X Cao, Y Peng, J Huang, L Chen… - Phytomedicine, 2023 - Elsevier
Background Hepatic lipid accumulation was a major promoter for the further development of
non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes (T2DM). mTOR/YY1 signaling …

Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based …

KS Kim, S Hong, K Han, CY Park - bmj, 2024 - bmj.com
Objective To investigate the risk of non-alcoholic fatty liver disease (NAFLD) for
cardiovascular disease and all cause death in patients with type 2 diabetes mellitus (T2DM) …

Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis

MYZ Wong, JJL Yap, R Sultana, M Cheah… - Open …, 2021 - openheart.bmj.com
Background Non-alcoholic fatty liver disease (NAFLD) is a well-established risk factor for
cardiovascular disease, with ethnic and regional differences noted. With the recent surge of …